Pigmentation Disorders
Conference Coverage
Review finds microneedling an effective add-on to topical melasma therapies
Twelve studies involving 459 patients from seven countries were included in the final analysis.
Dx Across the Skin Color Spectrum
Seborrheic Dermatitis
Seborrheic dermatitis affects patients of all ages: infants, adolescents, and adults. It is among the most common dermatologic diagnoses reported...
Conference Coverage
Major increase seen in cosmeceutical alternatives to topical hydroquinone
Cosmeceutical alternatives for hydroquinone, an agent now restricted by the FDA, have proliferated.
Case Letter
Paraneoplastic Signs in Bladder Transitional Cell Carcinoma: An Unusual Presentation
Paraneoplastic conditions may present secondary to urologic malignancy. Providers should perform thorough malignancy screening, including urologic...
Photo Challenge
Chronic Hyperpigmented Patches on the Legs
A 37-year-old man with a history of cerebral palsy, bipolar disorder, and impulse control disorder presented to the emergency department with...
Conference Coverage
Ruxolitinib cream meets primary endpoints in phase 3 vitiligo trial
These findings not only include substantial clinical efficacy but good tolerability with “no serious treatment-related adverse events.”
Aesthetic Dermatology Update
Acid series: Lactic acid
One of the most commonly used organic acids used on the skin, lactic acid, has been used for over 3 decades.
From the Journals
Insurance coverage for vitiligo varies widely in the U.S., analysis finds
“Lack of recognition from health care insurers makes treatments both less accessible and affordable, and only further marginalizes patients with...
Conference Coverage
When is MRI useful in the management of congenital melanocytic nevi?
All patients with findings suggestive of CNS melanin had more than four nevi present at birth, which is in line with current imaging screening...
Conference Coverage
Nadolol bests propranolol for infantile hemangioma treatment out to 52 weeks
Kaplan-Meir analysis showed that patients in the propranolol group responded slower to treatment (P = .019), while safety data was...
Case Letter
Pigmented Basal Cell Carcinoma With Annular Leukoderma
The halo phenomenon may accompany malignant processes, such as nonmelanoma skin cancer. Careful consideration of lesion time course and atypia is...